Status:
RECRUITING
Modulating Cortical Excitability to Improve Functional Movements in Individuals With Patellofemoral Pain
Lead Sponsor:
University of Nevada, Las Vegas
Conditions:
Patellofemoral Pain Syndrome
Eligibility:
All Genders
18-45 years
Phase:
NA
Brief Summary
This study sought to investigate whether modulation of cortical excitability of the gluteal musculature, via tDCS paired with exercise, will reduce the amount the knee caves in during functional tasks...
Eligibility Criteria
Inclusion
- are between 18 and 45 years old
- have had patellofemoral pain (PFP; kneecap pain) on one side for at least 3 months, and 3) the knee does cave in when performing functional movements.
Exclusion
- do not have pain coming from the kneecap during screening;
- have a history of knee injury or surgery,
- have a history of seizures and/or taking anti-seizure medication,
- have an implanted device that interacts with electric current,
- have a history of balance disorder,
- currently are pregnant or think they may be pregnant.
Key Trial Info
Start Date :
April 24 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 21 2025
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06565520
Start Date
April 24 2024
End Date
April 21 2025
Last Update
August 22 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Nevada, Las Vegas
Las Vegas, Nevada, United States, 89154